Plasma-derived factors VIIa and X mixtures (Byclot

Blood Coagulation / drug effects Coagulants Dose-Response Relationship, Drug Drug Combinations Factor VIIa / pharmacology Factor X / pharmacology Hemophilia A / blood Humans In Vitro Techniques
Acquired hemophilia A Bypassing agent Clot waveform analysis Inhibitor Plasma-derived FVIIa/FX

Journal

International journal of hematology
ISSN: 1865-3774
Titre abrégé: Int J Hematol
Pays: Japan
ID NLM: 9111627

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 25 11 2019
accepted: 23 01 2020
revised: 21 01 2020
pubmed: 8 2 2020
medline: 30 9 2020
entrez: 8 2 2020
Statut: ppublish

Résumé

A combined product of plasma-derived factor (F)VIIa and FX (pd-FVIIa/FX; Byclot

Identifiants

DOI: 10.1007/s12185-020-02837-6 PMID: 32030609
pubmed: 32030609
doi: 10.1007/s12185-020-02837-6
pii: 10.1007/s12185-020-02837-6
doi:

Substances chimiques

Coagulants 0
Drug Combinations 0
Factor X 9001-29-0
Factor VIIa EC 3.4.21.21

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

779-785

Auteurs

Satoshi Ochi (S)

Department of Pediatrics, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Masahiro Takeyama (M)

Department of Pediatrics, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan. mtake@naramed-u.ac.jp.
ORCID: 0000-0002-9348-9815

Midori Shima (M)

Department of Pediatrics, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Keiji Nogami (K)

Department of Pediatrics, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes physiologiques respiratoires et circulatoires › Phénomènes physiogiques du sang › Hémostase › Coagulation sanguine › Plasma-derived factors VIIa and X mixtures (Byclot
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents hématologiques › Coagulants › Plasma-derived factors VIIa and X mixtures (Byclot
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes toxicologiques › Relation dose-effet des médicaments › Plasma-derived factors VIIa and X mixtures (Byclot
questionsmedicales.fr › Préparations pharmaceutiques › Association médicamenteuse › Plasma-derived factors VIIa and X mixtures (Byclot
questionsmedicales.fr › Facteurs biologiques › Facteurs de la coagulation sanguine › Facteur VII › Facteur VIIa › Plasma-derived factors VIIa and X mixtures (Byclot
questionsmedicales.fr › Facteurs biologiques › Facteurs de la coagulation sanguine › Facteur X › Plasma-derived factors VIIa and X mixtures (Byclot
questionsmedicales.fr › Malformations et maladies congénitales, héréditaires et néonatales › Maladies génétiques congénitales › Troubles héréditaires de la coagulation sanguine › Hémophilie A › Plasma-derived factors VIIa and X mixtures (Byclot
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Plasma-derived factors VIIa and X mixtures (Byclot
questionsmedicales.fr › Techniques d'investigation › Techniques in vitro › Plasma-derived factors VIIa and X mixtures (Byclot